Abingdon Health plc is a leading biotechnology company specializing in the development, manufacturing, and commercialization of rapid diagnostic tests. The company's primary function is to provide accessible, point-of-care diagnostic solutions, which play a crucial role in the healthcare industry by enabling timely medical decisions. Abingdon Health's portfolio includes lateral flow tests for various applications, including infectious diseases, oncology, and clinical testing services. These tests are significant in sectors like public health, where quick results are vital for managing disease outbreaks, and in consumer health, where they support personal medical monitoring. Abingdon Health operates from its headquarters in the United Kingdom and collaborates with various healthcare providers and organizations worldwide, contributing to the global demand for efficient diagnostic tools. As part of the biotechnology market, the company influences innovation in healthcare diagnosis and is a notable player in the shift toward more decentralized healthcare solutions.